RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
57 hedge funds and large institutions have $129M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
8% less capital invested
Capital invested by funds: $140M → $129M (-$11.1M)
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.6M | |
| 2 | +$4.89M | |
| 3 | +$3.34M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.23M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$1.15M |
Top Sellers
| 1 | -$87.8M | |
| 2 | -$1.13M | |
| 3 | -$829K | |
| 4 |
Millennium Management
New York
|
-$727K |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
-$483K |